Form D Explorer

Inspect source fieldsReport a record issue

Form D — TriSalus Life Sciences, Inc.

0001231919-25-000045 · filed May 8, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$22,000,000
Reported amount sold
$22,000,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
TriSalus Life Sciences, Inc.
CIK
1826667
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2020
Address
6272 WEST 91ST AVENUE
WESTMINSTER, Colorado 80031
Phone
415 336 8917

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗